Zenith Health Care share news, announcements and annual reports
BSE: 530665Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹3.89.
30 Oct: open ₹3.97, high ₹3.97, low ₹3.70
- Under BSE's graded surveillance, stage I, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹20 Cr4,252nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 474.54
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.62
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 0.6%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −4.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 38,109
Zenith Health Care share news and announcements
537 announcements, routine notices left out, newest first. Page 3 of 11.
Sep 2023
Aug 2023
22 Aug · Board meeting
Meeting on 31 Aug 2023: annual general meeting2 Aug · Board meeting
Meeting on 12 Aug 2023: quarterly results
Jul 2023
10 Jul · Board meeting
10 Jul · Board meeting
3 Jul · Board meeting
Meeting on 10 Jul 2023
May 2023
29 May · Results
19 May · Board meeting
Meeting on 29 May 2023: audited results
Apr 2023
10 Apr · Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended 31St March 2023.
7 Apr · Compliance To Regulation No. 40(10) Of The SEBI (LODR) 2015.
7 Apr · Compliance To Regulation No. 40(10) Of The SEBI (LODR) 2015.
Mar 2023
Feb 2023
1 Feb · Board meeting
Meeting on 13 Feb 2023: quarterly results
Dec 2022
6 Dec · Disclosure Of Related Party Transactions
Nov 2022
2 Nov · Board meeting
Meeting on 12 Nov 2022: quarterly results
Oct 2022
12 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2022
5 Sep · Reg. 34 (1) Annual Report.
Aug 2022
23 Aug · Board meeting
Meeting on 30 Aug 2022: annual general meeting12 Aug · Outcome Of The Meeting Of Board Of Directors Held On 12Th August, 2022
3 Aug · Board meeting
Meeting on 12 Aug 2022: quarterly results
Jul 2022
8 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 1 0
Jun 2022
9 Jun · Disclosure Of Related Party Transactions